The transcription factor NFκB serves as a pivotal mediator of inflammatory responses and links persistent chronic inflammation to an increased risk of solid cancers and hematologic malignancies, including lymphoid neoplasms, AML, MDS, and MF [5, 41–44]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.